These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 11319181)
1. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer. Clifford JL; Sabichi AL; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Lippman SM Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):391-5. PubMed ID: 11319181 [TBL] [Abstract][Full Text] [Related]
2. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells. Sun SY; Yue P; Kelloff GJ; Steele VE; Lippman SM; Hong WK; Lotan R Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):595-601. PubMed ID: 11401908 [TBL] [Abstract][Full Text] [Related]
3. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites. Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536 [TBL] [Abstract][Full Text] [Related]
4. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells. Zou C; Liebert M; Zou C; Grossman HB; Lotan R J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527 [TBL] [Abstract][Full Text] [Related]
5. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines. Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596 [TBL] [Abstract][Full Text] [Related]
6. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Oridate N; Lotan D; Xu XC; Hong WK; Lotan R Clin Cancer Res; 1996 May; 2(5):855-63. PubMed ID: 9816241 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR). Xia Y; Wong NS; Fong WF; Tideman H Int J Cancer; 2002 Nov; 102(1):7-14. PubMed ID: 12353227 [TBL] [Abstract][Full Text] [Related]
9. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells. Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells. Lim SJ; Simeone AM; Kim CK; Tari AM Int J Cancer; 2002 Sep; 101(3):243-7. PubMed ID: 12209974 [TBL] [Abstract][Full Text] [Related]
11. The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells. Hail N; Chen P; Wempe MF Free Radic Biol Med; 2010 Dec; 49(12):2001-9. PubMed ID: 20923701 [TBL] [Abstract][Full Text] [Related]
12. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway. Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855 [TBL] [Abstract][Full Text] [Related]
13. Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Suzuki S; Higuchi M; Proske RJ; Oridate N; Hong WK; Lotan R Oncogene; 1999 Nov; 18(46):6380-7. PubMed ID: 10597238 [TBL] [Abstract][Full Text] [Related]
14. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979 [TBL] [Abstract][Full Text] [Related]
15. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy? Ohlmann CH; Jung C; Jaques G Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis. Hail N; Lotan R Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1293-301. PubMed ID: 11142414 [TBL] [Abstract][Full Text] [Related]
17. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Oridate N; Suzuki S; Higuchi M; Mitchell MF; Hong WK; Lotan R J Natl Cancer Inst; 1997 Aug; 89(16):1191-8. PubMed ID: 9274913 [TBL] [Abstract][Full Text] [Related]
18. How retinoids regulate breast cancer cell proliferation and apoptosis. Simeone AM; Tari AM Cell Mol Life Sci; 2004 Jun; 61(12):1475-84. PubMed ID: 15197471 [TBL] [Abstract][Full Text] [Related]
19. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta-glucuronide. Formelli F; Barua AB; Olson JA FASEB J; 1996 Jul; 10(9):1014-24. PubMed ID: 8801162 [TBL] [Abstract][Full Text] [Related]
20. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line. Holmes WF; Soprano DR; Soprano KJ J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]